Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 55: 1051-1052, 2009. First published April 16, 2009; 10.1373/clinchem.2009.125518
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2009.125518v1
55/6/1051    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chasman, D. I.
Right arrow Articles by Paré, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chasman, D. I.
Right arrow Articles by Paré, G.
(Clinical Chemistry. 2009;55:1051-1052.)
© 2009 American Association for Clinical Chemistry, Inc.


Editorials

Getting Closer to P-Selectin

Daniel I. Chasman1,a and Guillaume Paré1

1 Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

aAddress correspondence to this author at: Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Avenue, East, 02215, Boston, MA. Fax 617-232-3541; e-mail dchasman@rics.bwh.harvard.edu.

The first 20% of the full text of this article appears below.

Inflammation is recognized for its important role in the pathophysiology of atherosclerosis (1). However, the use of genetic association studies to dissect the impact of inflammatory genes on vascular disease is challenging because of the relatively small effects expected for common variants and the difficulty of identifying surrogates that best reflect underlying disease processes. In this issue of Clinical Chemistry, Volcik and colleagues (2) suggest an original design to address these issues by looking for genetic associations with the cell-surface concentration of a pair of cognate cell-surface receptors, P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1).1 P-selectin [encoded by the selectin P (granule membrane protein 140kDa, antigen CD62) (SELP) gene2 ] is primarily stored in platelets and endothelial cells, but it translocates to the cell surface upon activation and binding to its counterreceptor PSGL-1 [encoded by the selectin P ligand (SELPLG) gene] located on leukocytes. Adhesion of leukocytes to endothelium, with subsequent migration into the vascular wall, similarly involves P-selectin interaction with PSGL-1. Thus, the P-selectin–PSGL-1 interaction is thought to be of central importance in thrombosis, hemostasis, and vascular inflammation. A role for the P-selectin system in atherogenesis is indicated by decreased atherosclerotic plaques among apolipoprotein E (APOE –/–) mice also deficient in either platelet or endothelial P-selectin (3). More . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Association for Clinical Chemistry.